Bayer stock weighs on Roundup settlement hopes

Published on 09/15/2026 at 14:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock traded at EUR 49.19 on September 15, 2026, down 0.3 percent. The Monsanto unit is pushing a USD 7.25 billion Roundup settlement in Missouri.

Forscherin im weißen Kittel pipettiert an einem beleuchteten Laborarbeitsplatz vor einem Bildschirm mit 3D-Molekülstruktur — Pharmazeutisches Forschungslabor – Wissenschaftlerin mit Pipette, Molekülstruktur-Monitor, blaue LED-Beleuchtung, Illustration mit AI erstellt.

Bayer stock (ISIN DE000BAY0017) traded at EUR 49.19 on Xetra on September 15, 2026, down 0.3 percent from the prior session, with 622,199 shares changing hands by 12:28 p.m. The Monsanto unit is pressing a Missouri judge to approve a USD 7.25 billion Roundup settlement, Reuters reported on September 14, 2026.

Roundup settlement stays central

The legal issue is still the main market driver. finanzen.ch reported on September 15, 2026 that Bayer was seeking approval for the settlement, while the article cited a share price of CHF 46.49 in its market snapshot.

That follows a stronger session on September 14, 2026, when the same portal said Bayer gained 2.1 percent and traded at EUR 49.79 at the open before moving as high as EUR 50.32. The stock also finished that day with 1,750,939 shares traded, which points to clearly higher turnover than in the current session.

Quarterly figures still matter

For the latest reported quarter ended June 30, 2026, Bayer posted revenue of EUR 10.87 billion, up 1.24 percent from EUR 10.74 billion a year earlier. Net earnings per share were EUR 0.23, versus EUR -0.20 in the prior-year quarter, and the next report was listed for November 3, 2026 by finanzen.ch on September 14, 2026.

Analyst backdrop remains constructive. The same September 15, 2026 finanzen.ch note listed Deutsche Bank at Buy on September 10, 2026, Barclays at Overweight on September 8, 2026, JPMorgan at Overweight on September 3, 2026, UBS at Buy on September 1, 2026 and Jefferies at Hold on August 10, 2026.

Stock stays in the range

At EUR 49.19, Bayer stock remains below the September 14 intraday high of EUR 50.32 and above the 52-week low of EUR 25.78 cited by finanzen.ch. The 52-week high was EUR 53.92, so the share price sat EUR 4.73 below that level on September 15, 2026.